| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/17/1996 | CN1120468A Multi dentate heterodesmic Rh catalyst and its prepn. method |
| 04/17/1996 | CN1120458A Physiologically active peptide compositions |
| 04/17/1996 | CN1120449A Chinese medicinal capsule for giving up drugs |
| 04/17/1996 | CN1120446A Medical cream for mastitis |
| 04/17/1996 | CN1120436A A remedy for bronchial asthma |
| 04/16/1996 | US5508307 Administering lithium salts of fatty acids intravenously, monitoring plasma lithium levels to avoid hemolysis |
| 04/16/1996 | US5508279 Increases urine flow while avoiding hypotensive effects |
| 04/16/1996 | US5508276 Having duloxetine core, hydroxypropyl methyl cellulose acetate succinate enteric layer |
| 04/16/1996 | US5508269 Aminoglycoside formulation for aerosolization |
| 04/16/1996 | US5508268 Oxidatively stable solution; antibiotic anticancer agent |
| 04/16/1996 | US5508060 Swelling polymer substrate in supercritical fluid so that carrier and additive penetrates and is trapped within polymer |
| 04/16/1996 | US5508044 Controlled release form and hydrochlorothiazide immediate release form; treatment of hypertension |
| 04/16/1996 | US5508043 Sodium alginate and a calcium salt which crosslinks with the alginate when exposed to aqueous solutions; administered orally with a higher aliphatic alcohol |
| 04/16/1996 | US5508042 Administering an oral dosage every 12 hours |
| 04/16/1996 | US5508041 Microencapsulation for controlled oral drug delivery system |
| 04/16/1996 | US5508040 Multiparticulate pulsatile drug delivery system |
| 04/16/1996 | US5508039 Controlled transdermal administration of melatonin |
| 04/16/1996 | US5508038 Drug delivery patches having mixture of high and low molecular weight polymers as adhesives which dissolve active agents, free of plasticizers and tackifiers |
| 04/16/1996 | US5508037 Stable suppository formulations effecting bioavailability of Δ9 -THC |
| 04/16/1996 | US5508030 Creating new capillary blood pools for practicing bidirectional medicine |
| 04/16/1996 | US5508023 Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant |
| 04/16/1996 | US5508022 Gelled emulsion particles and compositions in which they are present |
| 04/16/1996 | US5508021 Biocompatible crosslinked polymer containing imaging agent |
| 04/16/1996 | CA2062828C Pharmaceutical plasters |
| 04/16/1996 | CA2018230C Aqueous folinate solution - stable at refrigerator temperature, as well as process for its preparation |
| 04/14/1996 | CA2160190A1 Process for microencapsulation using oil-soluble emulsifiers |
| 04/11/1996 | WO1996010585A1 Glycosylated protein-liposome conjugates and methods for their preparation |
| 04/11/1996 | WO1996010555A1 Cationic transport reagents |
| 04/11/1996 | WO1996010454A1 Polyhydroxybutyrate and polyphosphate membranes with channels |
| 04/11/1996 | WO1996010429A2 Improved transdermal device having decreased delamination |
| 04/11/1996 | WO1996010428A1 Differentially biodegradable biomedical implants |
| 04/11/1996 | WO1996010421A1 Vaccine compositions |
| 04/11/1996 | WO1996010416A1 DRUGS CONTAINING β-INTERFERON |
| 04/11/1996 | WO1996010413A1 Compositions containing tumor rejection antigen precursors or tumor rejection antigens, and an adjuvant and/or growth factor |
| 04/11/1996 | WO1996010409A2 Liquid antacid compositions containing calcium carbonate and possibly simethicone as active compounds and monobasic potassium phosphate and potassium bicarbonate as buffer |
| 04/11/1996 | WO1996010406A1 Pharmaceutical composition of fantofarone for oral administration |
| 04/11/1996 | WO1996010399A1 Liposome-formulations for treatment of viral diseases |
| 04/11/1996 | WO1996010398A1 Method for forming and packaging iontophoretic drug delivery patches and the like to increase stability and shelf-life |
| 04/11/1996 | WO1996010397A1 Oral sustained-release preparation |
| 04/11/1996 | WO1996010396A1 Carbon-substituted diketopiperazine delivery systems |
| 04/11/1996 | WO1996010395A1 Controlled-release pharmaceutical preparations |
| 04/11/1996 | WO1996010394A1 Method of binding recognizing substances to liposomes |
| 04/11/1996 | WO1996010393A1 Liposomes with enhanced entrapment capacity, method and use |
| 04/11/1996 | WO1996010392A1 Bilayer stabilizing components and their use in forming programmable fusogenic liposomes |
| 04/11/1996 | WO1996010391A1 Polyethylene glycol modified ceramide lipids and liposome uses thereof |
| 04/11/1996 | WO1996010390A1 Novel compositions for the introduction of polyanionic materials into cells |
| 04/11/1996 | WO1996010389A1 Pharmaceutical composition |
| 04/11/1996 | WO1996010374A1 Differentially biodegradable biomedical implants |
| 04/11/1996 | DE4435805A1 Zweikomponenten-Creme Two-cream |
| 04/11/1996 | DE4435563A1 Gel from hyaluronic acid and plant oil |
| 04/11/1996 | CA2201614A1 Liquid antacid compositions containing calcium carbonate and possibly simethicone as active compounds and monobasic potassium phosphate and potassium bicarbonate as buffer |
| 04/11/1996 | CA2201354A1 Method for forming and packaging iontophoretic drug delivery patches and the like to increase stability and shelf-life |
| 04/11/1996 | CA2201327A1 Compositions containing tumor rejection antigen precursors or tumor rejection antigens, and an adjuvant and/or growth factor |
| 04/11/1996 | CA2199154A1 The use of medicaments containing interferon-beta |
| 04/11/1996 | CA2197327A1 Oral sustained-release preparation |
| 04/11/1996 | CA2176566A1 Method of binding recognizing substances to liposomes |
| 04/10/1996 | EP0705599A1 Use of N-(hydroxyalkyl)-substituted alkyl carbamates as tensioactive agents in cosmetic composition |
| 04/10/1996 | EP0705593A1 Dermatologic or cosmetic composition made up by an oil in water emulsion based on oily globules coated with a lamellar liquid crystal coating |
| 04/10/1996 | EP0705255A1 N-morpholino-n-nitrosaminoacetonitril cyclodextrin inclusion complexes |
| 04/10/1996 | EP0705125A1 Drying water-containing valuable substances or mixtures thereof with superheated steam |
| 04/10/1996 | EP0705113A1 Dried hydrogel from hydrophylic-hygroscopic polymer |
| 04/10/1996 | EP0705101A1 Antiparasitic compositions |
| 04/10/1996 | EP0705096A1 Surface-modified albumin microspheres and pharmaceutical compositions containing them |
| 04/10/1996 | EP0705095A1 Combinations of viscoelastics for use during surgery |
| 04/10/1996 | EP0705085A1 Molecular transdermal transport system |
| 04/10/1996 | EP0641195B1 Process for preparing delayed-action medicinal compositions |
| 04/10/1996 | EP0579703B1 Inhibition of aggregation of drug containing particles |
| 04/10/1996 | EP0552299B1 Liposome extrusion process |
| 04/10/1996 | EP0512095B1 Methyl pyrrolidinone chitosan, production process and uses thereof |
| 04/10/1996 | EP0352295B2 Biodadhesion drug carriers for endothelial and epithelial uptake and lesional localization of therapeutic and diagnostic agents |
| 04/10/1996 | CN1120316A HIV protease inhibitors in pharmaceutical combinations for the treatment of AIDS |
| 04/10/1996 | CN1120312A Retarded-action microtablet made of beta-phenylpropiophenone derivatives |
| 04/10/1996 | CN1120311A Pharmaceutical composition containing lipophilic drugs |
| 04/10/1996 | CN1120310A Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces |
| 04/10/1996 | CN1119961A Reverse washing method of water processing apparatus using floating filtering material |
| 04/10/1996 | CN1119943A Efficient frostbite prevention and anti-crack cream and its preparation technology |
| 04/10/1996 | CN1119934A Process and apparatus for making tablets and tablets made therefrom |
| 04/09/1996 | US5506248 Salt of ifetroban and one or more basifying agents |
| 04/09/1996 | US5506231 Administering an antagonist of excitatory amino acids to reduce central nervous system disorder caused by human immunodeficiency virus infection |
| 04/09/1996 | US5506230 Oil in water emulsion consists of 2,3-dihydro-1h indene cmpound, an oil, phospholipid as an emulsifier, glycerol as an isotonic agent and water; useful for improving anoxemic and hypoxic syndromes, prevents arrythemia and heart failure |
| 04/09/1996 | US5506218 Intravenously administering a protein and peptide free phospholipid and neutral lipid to the subject; prophylaxis |
| 04/09/1996 | US5506216 Cyclodextrin-biocide complex |
| 04/09/1996 | US5506203 Systemic administration of a therapeutic preparation |
| 04/09/1996 | US5505983 Spherical seed cores, spherical granules and process for production thereof |
| 04/09/1996 | US5505967 Pharmaceutical loaded into alkali insoluble particle in enteric material; for delivery to peyer's glands |
| 04/09/1996 | US5505966 Therapeutical composition and process for its preparation |
| 04/09/1996 | US5505965 Coating with propylene glycol and a carrier selected from titanium dioxide, zinc oxide and aluminum hydroxide; improves sunburn protection factor |
| 04/09/1996 | US5505963 Slow release pharmaceutical preparation |
| 04/09/1996 | US5505962 Improved controlled release tablet formulation for release of potassium chloride through differentially permeable membrane to prevent irritation of gastric mucosa |
| 04/09/1996 | US5505961 Increasing solubility |
| 04/09/1996 | US5505960 Liposomal piroxicam formulations |
| 04/09/1996 | US5505959 Pharmaceutical composition in gel form in a dispensing package |
| 04/09/1996 | US5505958 Transdermal drug delivery device and method for its manufacture |
| 04/09/1996 | US5505957 Selectable dosage transdermal delivery system |
| 04/09/1996 | US5505956 Transdermal skin patch |
| 04/09/1996 | US5505954 Also containing carboxypolymethylene, edta; preventing secondary hemorrhage |
| 04/09/1996 | US5505953 Use of borate-polyol complexes in ophthalmic compositions |
| 04/09/1996 | US5505949 Mixture of clortrimazole, betamethasone and salicylic acid |
| 04/09/1996 | US5505945 Method and compositions for the direct concentrated delivery of passive immunity |
| 04/09/1996 | US5505932 Method for the preparation of fluorocarbon-containing polymeric shells for medical imaging |